Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1059409]Researchers: Prof Magdalena Plebanski (Principal investigator)
Brief description Vaccines require adjuvants to be effective. Despite decades of research there is only one adjuvant approved for broad use in humans. Based on our prior findings I will engage new principles in nanotechnology, and deepen understanding of immune imprinting in various organs of the body including the lung, to develop 2nd generation broadly useful nanoadjuvants able to effectively treat cancer and malaria.
Funding Amount $AUD 631,010.39
Funding Scheme Research Fellowships
Notes Research Fellowship
- nhmrc : 1059409
- PURL : https://purl.org/au-research/grants/nhmrc/1059409
